Table 1.
Clinical, laboratory and histopathological characteristics of the studied patients n (%)
| Parameter | HCV patients (n = 30) |
| Clinical findings | |
| Jaundice | 0 (0.0) |
| Hepatomegaly | 4 (13.3) |
| Splenomegaly | 1 (3.3) |
| Ascites | 0 (0.0) |
| Liver function tests | |
| Total bilirubin (mg/dL) | 1.23 ± 1.051 |
| Direct bilirubin (mg/dL) | 0.30 ± 0.26 |
| Albumin (g/L) | 43.17 ± 7.5 |
| Alanine transaminase (U/L) | 55.57 ± 126.16 |
| Aspartate transaminase (U/L) | 72.10 ± 131.97 |
| Gamma glutamyl transpeptidase (U/L) | 38.90 ± 21.92 |
| Alkaline phosphatase (U/L) | 253.48 ± 97.38 |
| Complete blood count | |
| Hemoglobin (g/L) | 113.6 ± 11.2 |
| White blood cells (× 103/ L) | 8.77 ± 7.52 |
| Platelets (× 103/L) | 383.57 ± 390.87 |
| Fibrosis stage | |
| No (F0) | 1 (3.3) |
| Mild (F1) | 12 (40) |
| Moderate (F2-F3) | 17 (56.7) |
| Activity grade | |
| Minimal | 10 (33.3) |
| Mild | 20 (66.7) |
| Steatosis | 8 (26.7) |
HCV: Hepatitis C virus; F0/1/2/3: Fibrosis score 0/1/2/3.